MedPath

GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study

Not yet recruiting
Conditions
Glaucoma Open-Angle Primary
Ocular Hypertension
Registration Number
NCT07210216
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

This observational study aims to identify early diagnostic markers of glaucomatous damage by combining functional and structural assessments. Patients with primary open-angle glaucoma and ocular hypertension will undergo comprehensive ophthalmological evaluation, including visual field testing and multimodal imaging of the optic nerve and retina. Both retrospective and prospective data will be collected. The main objective is to define new diagnostic paradigms for detecting early glaucomatous changes and to improve the accuracy of current clinical practice in glaucoma management.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age between 40 and 90 years.
  • Best-corrected visual acuity ≥ 0.1 LogMAR (≥ 8/10).
  • For primary open-angle glaucoma (POAG):
  • IOP ≥ 21 mmHg with normal visual field and/or normal optic nerve head/RNFL, or
  • Suspicious optic nerve head (excavation), or
  • Reproducible glaucomatous visual field defect.
  • POAG patients stratified by visual field mean deviation (MD): -3 to -10 dB (S1-S2 Brusini classification).
Exclusion Criteria
  • Best-corrected visual acuity worse than 0.1 LogMAR (< 8/10).
  • Ocular surgery in the last 6 months (except uncomplicated cataract extraction).
  • Previous vitreoretinal surgery for macular pathologies (e.g., macular pucker, macular hole) or retinal detachment.
  • High myopia (> -3 diopters).
  • Optic disc anomalies not attributable to glaucoma (tilted disc, papillary drusen, other morphological/functional anomalies).
  • Severe motor disability preventing proper positioning for tests.
  • Cognitive impairment reducing test reliability.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of early glaucomatous damage detected by multimodal imagingBaseline to 24 months

Evaluation of structural parameters from OCT and OCTA and functional indices from visual field testing to detect early glaucomatous damage in ocular hypertensive and glaucoma patients.

Secondary Outcome Measures
NameTimeMethod
Correlation between OCT structural parameters and visual field indicesBaseline to 24 months

Analysis of the association between RNFL/GCC thickness and visual field MD, PSD, and other indices.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.